Search PubMed⌕ Search

Biomedical subjects

A Misra

Publications and source records attributed to A Misra.

At least 109 records · Page 6Linked to original sources

Esophageal achalasia presenting during pregnancy.

We report a woman with achalasia cardia who developed dysphagia for the first time during pregnancy. She was initially mistakenly treated elsewhere as hyperemesis gravidarum. The diagnosis and treatment of achalasia during pregnancy is reviewed.

Adult↗

Electrophysiologic differences in young patients with atrial fibrillation. Influence of preexcitation.

Paroxysmal atrial fibrillation is a common arrhythmia, which may occur in young patients without known structural heart disease, with or without preexcitation. Elimination of an accessory pathway in these patients may prevent not only orthodromic and antidromic tachycardia but also atrial fibrillation. However, abnormalities of atrial conduction and refractoriness have been reported, suggesting that atrial fibrillation may still recur in these patients. In a review of all electrophysiologic studies performed at the authors' institution since January 1990 in patients under age 60 years of age without identifiable heart disease, 24 patients with atrial fibrillation were identified whose electrophysiologic measurements of a right atrial conduction and effective refractory period of the right atrium and accessory pathway were in sinus rhythm. Of these patients, 12 had preexcitation and the other 12 did not. These patients were compared with age- and sex-matched control subjects, 12 with preexcitation without atrial fibrillation and 13 without preexcitation or atrial fibrillation, respectively. Electrophysiologic abnormalities were noted in patients with atrial fibrillation depending on the presence or absence of preexcitation. In patients with preexcitation, these abnormalities were a shorter refractory period of the right atrium (212 +/- 33 ms) and of the accessory pathway (251 +/- 27 ms), compared with control subjects (241 +/- 27 ms, P < .05 and 306 +/- 61 ms, P < .02, respectively). In patients without preexcitation, conduction abnormality in the form of prolonged atrial conduction time when compared with control subjects (48 +/- 26 ms vs 31 +/- 10 ms, P < .05) was noted. These findings may influence the type of antiarrhythmic drug used in these patients, and if confirmed in a larger study, they may lead to a better understanding of factors influencing the development of atrial fibrillation in young patients.

Adult↗

A behavioural and neurochemical study in rats of the pharmacology of loreclezole, a novel allosteric modulator of the GABAA receptor.

Loreclezole is an anticonvulsant and anxiolytic compound which has been reported to potentiate GABA via a novel allosteric site on the beta-subunit of the receptor. We have now studied in rats both the in vivo and in vitro pharmacology of the compound. The dose of loreclezole required to increase by 50% the dose of intravenous pentylenetetrazol eliciting a seizure was comparable to that of barbiturates and chlormethiazole (in mg/kg): diazepam, 1.3; pentobarbitone, 16; chlormethiazole, 22; loreclezole, 25; pentobarbitone, 36. Loreclezole dose-dependently decreased locomotion (dose to decrease locomotion by 50% (in mg/kg): chlormethiazole, 9; pentobarbitone, 16; loreclezole, 25). Loreclezole, chlormethiazole and pentobarbitone all failed to displace [3H]muscimol and [3H]flunitrazepam binding from a rat cortical membrane preparation. All three compounds fully displaced [35S]TBPS binding (IC50 values: loreclezole, 4.34 +/- 0.68 microM; pentobarbitone, 37.39 +/- 3.24 microM; chlormethiazole, 82.10 +/- 8.52 microM). Addition of bicuculline (10 microM) produced a major rightward shift in the loreclezole and pentobarbitone displacement curves, increasing IC50 values for [35S]TBPS binding by 25 times (loreclezole), 6 times (pentobarbitone) and 2.7 times (chlormethiazole), suggesting a greater involvement of GABA in the interaction of loreclezole with the chloride channel than in the case of chlormethiazole. Anticonvulsant activity of the compounds did not appear to relate to [35S]TBPS binding activity. Other binding data suggested that although the evidence of others indicates that loreclezole interacts with a specific allosteric site on the beta-subunit, it nevertheless also alters the binding characteristics of other modulatory sites.

Allosteric Regulation↗

The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine.

Dark Agouti rats injected with either p-chloroamphetamine (PCA; 2.5 mg/kg i.p.) or fenfluramine (15 mg/kg i.p.) had substantial decreases (approximately 50%) in the concentration of 5-HT and 5-HIAA and binding of [3H]paroxetine in the cerebral cortex 7 days later. This indicates that both compounds had produced neurodegeneration of 5-HT axon terminals. Two doses of alpha-phenyl-N-tert-butyl nitrone (PBN; 150 mg/kg i.p.) 130 min apart had no effect on cortical 5-HT content or [3H]paroxetine binding. However, when PBN (150 mg/ kg) was given 10 min before and 120 min after PCA (2.5 mg/kg) it attenuated the PCA-induced neurodegeneration. In contrast, PBN was without significant effect on the fenfluramine-induced damage. Changes in rectal temperature following either the neurotoxins or neurotoxins+ PBN were no more than +/-1 degree C of saline-injected control rats. These data indicate that PCA, like MDMA, probably induces neurotoxic degeneration because of the formation of catechol or quinone metabolites and subsequent reactive tree radical formation. Such a mechanism does not appear to explain fenfluramine-induced damage to 5-HT neurones.

Animals↗

Production of nitrite by dengue virus-induced cytotoxic factor.

Dengue type 2 virus (DV) infection induces production of a cytokine, the cytotoxic factor (CF) in the spleen of mice. The present study was undertaken to investigate the production of nitrite (NO2-) by the spleen cells of mice in vitro and in vivo following inoculation of DV or CF. Maximum NO2- production occurred at 45 min after inoculation of 5 microg CF, both in vitro and in vivo. The NO2- was produced by macrophages and T cells and not by B cells. Pretreatment of CF with anti-CF antisera inhibited production of NO2-. DV-stimulated spleen cell culture supernatants showed peak production of CF and NO2- at 72h. In DV-infected mouse spleen, maximum NO2- production occurred at 8-11 days post-infection, which correlated with peak cytotoxic activity in the spleen. Pretreatment of spleen cells with N(G)-monomethyl L-arginine (NMMA) inhibited NO2- production. NO2- production was abrogated in a dose-dependent manner by treatment of spleen cells with Ca2+ channel blocking drug, Nifedipine. The findings demonstrate that DV-induced CF induces production of NO2- in spleen cells, probably in a Ca2+-dependent manner, and may be a mechanism of target cell killing.

Animals↗

Dengue virus-induced cytotoxin releases nitrite by spleen cells.

Dengue type-2 virus (DV) infection in mice induces T cells to produce a cytokine, the cytotoxic factor (CF), which induces H2-A positive macrophages to produce another cytokine, cyototoxic (CF2), which amplifies its cytotoxic effects on target cells. The present study was undertaken to investigate the production of nitrite (NO2-) by the spleen cells of mice in vitro and in vivo following inoculation of CF2. Maximum NO2- production occurred at 1 hour after inoculation of 100 micrograms CF2. Pretreatment of CF2 with anti-CF2-antisera (CF2-As) inhibited the production of NO2-. Pretreatment of the spleen cells with NG-monomethyl-L-arginine (NMA) or with arginase inhibited NO2- production. The NO2- production was diminished in a dose dependent manner by treatment of spleen cells with the Ca2+ channel blocking drug, nifedipine and Zn2+ as ZnSO4. The findings of the present study thus demonstrate that CF2 induces production of NO2- in the spleen cells in a CA(2+)-dependent manner which may be a mechanism of target cell killing.

Animals↗

Release of reactive oxygen intermediates by dengue virus-induced macrophage cytotoxin.

Dengue type 2 virus (DV) induces a subpopulation of T lymphocytes of mice to produce a cytokine, cytotoxic factor (mCF), which induces H-2A positive macrophages to produce macrophage cytotoxin (CF2). The present study was undertaken to investigate the mechanism of cytotoxicity of CF2. It was observed that CF2 induced production of superoxide anion (O2-) and hydrogen peroxide (H2O2) by the spleen cells of mice in vitro and in vivo. The maximum production of O2- (260 +/- 10 nM/4 x 10(6) cells) was at 45 minutes while that of H2O2 was at 90 minutes after inoculation of CF2. Pretreatment of mice or spleen cells with anti-CF2-antisera inhibited O2- and H2O2 production in a dose-dependent manner. Superoxide dismutase (SOD) inhibited O2- production and cytotoxicity while H2O2 production was increased by increasing SOD concentration in the culture. This indicated that O2- production is necessary for the cytotoxic activity of CF2. Pretreatment of the cells with Ca2+ channel blocking drugs, nifedipine or verapamil, inhibited CF2-induced O2- and H2O2 production in a dose-dependent manner. We have shown earlier that the cytotoxic activity of CF2 is known to be Ca2+ dependent and CF2-induced production of nitrite and the cytotoxicity is inhibited by NG-monomethyl-L-arginine. Thus, it is suggested that O2- and nitrite are necessary for cell killing by CF2 in a Ca(2+)-dependent manner and the killing may possibly be by generation of peroxynitrite.

Animals↗

Percutaneous drainage of renal hydatid cyst: early results and follow-up.

OBJECTIVE: To evaluate a combination of percutaneous drainage and medical prophylaxis in the treatment of renal hydatid cyst to assist renal preservation, decrease morbidity and shorten the duration of hospital stay. PATIENTS AND METHODS: Four patients (three men and a woman, age range 26-31 years) with non-communicating renal hydatid cysts were selected for treatment using percutaneous drainage. This was performed under medical prophylaxis with albendazole and praziquentel. Ethanol (95%) was used as a scolicidal agent. RESULTS: The method was successful in preserving three of four renal units but one unit was ablated because of secondary infection and haematuria. The kidneys of three patients were functioning adequately after a mean follow-up of 21.6 months from percutaneous drainage. CONCLUSIONS: Percutaneous drainage of renal hydatid cysts is a safe and effective method for preventing renal loss, and decreasing morbidity and the duration of hospital stay. It should be employed as the first option for renal hydatid disease.

Adult↗

The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice.

1. The ability of two dihydropyridine calcium channel antagonists, felodipine and nitrendipine both to displace [3H]-isradipine binding in CNS tissue measured ex vivo and to protect against the ethanol withdrawal syndrome has been investigated. 2. Mice were injected with various doses of felodipine or nitrendipine and [3H]-isradipine binding measured in brain homogenates prepared 0.5, 3 or 5 h later. Inhibition versus dose curves were sigmoid and the dose required to produce 50% inhibition increased linearly with time after administration. Felodipine was approximately 10 times more potent than nitrendipine. 3. Nitrendipine (50 mg kg-1, i.p.) and felodipine (10 mg kg-1, i.p.) produced around a 75% inhibition of [3H]-isradipine binding 3 h later. Binding of [3H]-nitrendipine to cerebral tissues measured after in vivo injection of the ligand was decreased by nitrendipine (50 mg kg-1) and felodipine (10 mg kg-1) to a similar extent. 4. Nitrendipine (50 mg kg-1) prevented the behavioural signs of ethanol withdrawal as measured by handling induced convulsions, but felodipine (10 mg kg-1 or 2 mg kg-1) did not provide any protection against this effect of ethanol withdrawal. Felodipine (10 mg kg-1, twice daily) during the course of ethanol treatment also failed to attenuate the withdrawal syndrome. 5. The convulsive response to a mild audiogenic stimulus during ethanol withdrawal was increased following one dose of felodipine (5 mg kg-1, i.p.) but unaffected by nitrendipine. 6. Injection of Bay K 8644 (60 microgram, i.c.v.) produced a significant increase in handling-induced convulsive behaviour. Felodipine (10 mg kg-1, i.p.) reduced this behaviour both 60 and 120 min later, while nitrendipine (50 mg kg-1) showed a modest reduction only at 120 min.7. In contrast, nitrendipine (50mg kg-1) and felodipine (10 mg kg-1) produced similar effects on the hyperexcitability produced by handling following administration of bicuculline. Hexamethonium(8 mg kg-1) had no effect on this response.8. No change was found in [3H]-isradipine or [125I]-w-conotoxin binding to cerebral tissue prepared from ethanol-dependent mice.9. These results demonstrate that while felodipine and nitrendipine have similar actions on some CNS-mediated effects (raising seizure thresholds to several convulsant drugs), felodipine, in contrast to nitrendipine, has no effect on the ethanol withdrawal syndrome. Suggested explanations for the results include the possibility that nitrendipine may protect against the ethanol withdrawal syndrome via sites other than dihydropyridine receptors: that felodipine has partial agonist actions at dihydropyridine receptors in the CNS or that felodipine has actions which mask its protective effect in ethanol withdrawal.

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethy↗